Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Procaps Group S.A. PROC
$4.40
-$0.09 (-2.00%)
На 18:04, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
512785080.00000000
-
week52high
9.50
-
week52low
3.68
-
Revenue
409742000
-
P/E TTM
15
-
Beta
0.08100300
-
EPS
0.64000000
-
Last Dividend
0.00000000
-
Next Earnings Date
07 окт 2021 г. в 10:59
Описание компании
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. In addition, the company offers over-the-counter (OTC) consumer healthcare products through a portfolio on approximately eight therapeutic areas, including gastrointestinal, skin care, cough and cold, analgesics, urological, vitamins, minerals, and supplements in the categories of antibiotics, anti-infective, anti-parasitic, cardiovascular, feminine care, cutaneous antimycotic, pain killers, gastro intestinal, hormonals, metabolic, endocrine, nervous system, ophthalmic, osteoarticular, respiratory, diet supplements, and vitamins and minerals. Further, it provides blood glucose meters, telemonitoring products, oral anti-diabetics products, cosmeceuticals, insulin delivery systems, and other diabetes solutions; and contract drug development and manufacturing services to third party pharmaceutical companies, specializing in soft gelatin capsule technologies. The company was founded in 1977 and is based in Luxembourg, Luxembourg.
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
Procaps to Present at 2023 Annual J.P. Morgan Healthcare Conference
GlobeNewsWire
29 дек 2022 г. в 08:00
MIAMI and BARRANQUILLA, Colombia, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced that it will present at the 2023 J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at 8:00 am PST. At that time, Procaps will present its 2023 growth plans to investors.
Procaps Group, S.A. (PROC) Q3 2022 Earnings Call Transcript
Seeking Alpha
16 ноя 2022 г. в 17:57
Procaps Group, S.A. (NASDAQ:PROC ) Q3 2022 Earnings Conference Call November 16, 2022 4:00 PM ET Company Participants Melissa Angelini - IR, Director Ruben Minski - Founder, Chief Executive Officer and Director Patricio Vargas - Chief Financial Officer Conference Call Participants Kemp Dolliver - Brookline Capital Markets Operator Good day and welcome to the Procaps Group Business Update Call and Webcast.
Procaps Group to Report Third Quarter and Nine Months of 2022 on November 14, 2022
GlobeNewsWire
08 ноя 2022 г. в 15:36
MIAMI and BARRANQUILLA, Colombia, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced that it expects to report its results for the third quarter ended September 30, 2022, after the market closes on Monday, November 14, 2022.
Procaps Group, S.A. (PROC) CEO Ruben Minski on Q3 2021 Results - Earnings Call Transcript
Seeking Alpha
23 ноя 2021 г. в 19:59
Procaps Group, S.A. (PROC) CEO Ruben Minski on Q3 2021 Results - Earnings Call Transcript